What is Soma
SomatotropinThe Generic name of this drug
Treatment SummaryHuman growth hormone (HGH) is a peptide hormone made by the somatotropic cells in the pituitary gland. It helps regulate growth, metabolism, fat and muscle mass, and blood glucose levels. It’s been available as a recombinant form since 1985 and is available as a subcutaneous injection under various brand names. It is approved to treat growth hormone deficiency, growth failure, or short stature in children and adults, including conditions like Turner Syndrome, Prader-Willi Syndrome, Noonan Syndrome, and idiopathic short stature.
Humatropeis the brand name
Soma Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Humatrope
Somatotropin
1987
58
Approved as Treatment by the FDA
Somatotropin, also called Humatrope, is approved by the FDA for 33 uses like HIV Wasting Syndrome and Open epiphyses .HIV Wasting Syndrome
Helps manage HIV Wasting Syndrome
Open epiphyses
Helps manage Open epiphyses
Cachexia
Helps manage Cachexia
Congenital Diseases
Helps manage Congenital Diseases
Human Growth Hormone Deficiency
Helps manage Human Growth Hormone Deficiency
Hypopituitarism
Helps manage Hypopituitarism
Adult Onset Growth Hormone Deficiency
Helps manage Adult Onset Growth Hormone Deficiency
Parkinson Disease
Helps manage Idiopathic Disease
Acquired disease
Helps manage Acquired disease
Disease
Helps manage Small for Gestational Age (Disorder)
HIV
Helps manage Human Immunodeficiency Virus (HIV) Infections
Antiretroviral Therapy
Helps manage Antiretroviral Therapy
General Surgery
Helps manage General Surgery
SHOX deficiency
Helps manage SHOX deficiency
Traumatic Injury
Helps manage Traumas
Pituitary Diseases
Helps manage Pituitary Diseases
SHOX protein, human
Helps manage Idiopathic Short Stature (ISS)
Radiation Therapy
Helps manage Radiation Therapy
Growth Failure
Helps manage Growth Failure
Kidney Transplant
Helps manage Kidney Transplantation
Chronic Kidney Disease
Helps manage Chronic Kidney Disease (CKD)
Noonan Syndrome
Helps manage Noonan Syndrome
Short Stature
Helps manage Short Stature
Height standard deviation score (HSDS) of less than or equal to-2.25
Helps manage Height standard deviation score (HSDS) of less than or equal to-2.25
Childhood-onset Growth Hormone Deficiency
Helps manage Childhood-onset Growth Hormone Deficiency
Genetic Disease
Helps manage Genetic Disease
Growth rates unlikely to permit attainment of adult height in the normal range
Helps manage Growth rates unlikely to permit attainment of adult height in the normal range
Royer Syndrome
Helps manage Prader-Willi Syndrome
Short Bowel Syndrome (SBS)
Helps manage Short Bowel Syndrome (SBS)
Nutritional Support
Helps manage Nutritional Support
No catch-up growth by age 2 to 4 years
Helps manage No catch-up growth by age 2 to 4 years
Turners Syndrome
Helps manage Turners Syndrome
Hypothalamic and pituitary disorders NEC
Helps manage Hypothalamic and pituitary disorders NEC
Effectiveness
How Soma Affects PatientsSomatotropin is a hormone that increases the size of many different parts of the body, including muscles and internal organs, as well as increasing red blood cells. It helps the body retain potassium and phosphorus and promote protein synthesis. It may also improve nutritional parameters in people with end-stage renal disease. Somatotropin is known to cause insulin resistance, meaning it can make it harder for the body to use insulin to control blood sugar levels. It also increases the breakdown of fat and decreases LDL cholesterol levels. In contrast, it increases the uptake of fat in skeletal muscle. In some cases, it can also lead to an increase in
How Soma works in the bodySomatotropin is used to treat conditions of growth failure, growth hormone deficiency, low body mass, and malnutrition. It works by binding to a receptor called the human growth hormone receptor, which triggers the release of special molecules called transcription factors. These transcription factors help to regulate the genes that control growth, leading to increased muscle and bone mass, and reduced fat mass. Somatotropin also increases the production of a molecule called insulin-like growth factor-1, which further stimulates linear growth. In the liver, somatotropin increases the production of proteins that bind to insulin-like growth factor-1, making it last longer
When to interrupt dosage
The endorsed dosage of Soma is contingent upon the diagnosed condition, including Growth Failure, Pituitary Diseases and No catch-up growth by age 2 to 4 years. The portion likewise shifts as indicated by the technique of delivery featured in the table beneath.Condition
Dosage
Administration
Disease
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Royer Syndrome
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Traumatic Injury
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Open epiphyses
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
SHOX deficiency
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Childhood-onset Growth Hormone Deficiency
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Nutritional Support
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Hypothalamic and pituitary disorders NEC
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Short Stature
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Short Bowel Syndrome (SBS)
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Adult Onset Growth Hormone Deficiency
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
SHOX protein, human
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Antiretroviral Therapy
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Parkinson Disease
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Human Growth Hormone Deficiency
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Radiation Therapy
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Turners Syndrome
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Kidney Transplant
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Congenital Diseases
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Genetic Disease
10.0 mg/mL, 5.3 mg, 6.0 mg, 8.8 mg/mL, 5.0 mg/mL, 16.0 mg/mL, 13.5 mg/mL, 1.0 mg/mg, 1.8 mg, 20.0 mg/mL, 2.0 mg/mL, 10.0 mg, 5.0 mg, 4.0 mg/mL, 6.0 mg/mL, , 18.0 mg/mL, 0.2 mg, 5.8 mg/mL, 8.0 mg/mL, 5.83 mg/mL, 15.0 mg/mL, 1.0 mg, 4.0 mg, 7.0 mg, 1.3 mg/mL, 1.5 mg/mL, 8.8 mg, 0.6 mg, 2.0 mg, 0.8 mg, 20.0 mg, 12.0 mg, 1.6 mg, 1.2 mg, 1.4 mg, 0.4 mg, 4.8 mg, 3.3 mg, 12.0 mg/mL, 5.8 mg, 24.0 mg, 30.0 mg/mL, 14.0 mg/mL, 24.0 mg/mL, 5.0 mg/mg, 4.4 mg/mL, 22.5 mg/mL, 1.0 mg/mL
Subcutaneous, , Intramuscular; Subcutaneous, Kit, Injection, powder, for suspension, extended release - Subcutaneous, Liquid; Powder, for solution - Subcutaneous, Solution - Parenteral, Powder, for solution, Injection, powder, for solution, Injection, solution - Subcutaneous, Powder, for solution - Subcutaneous, Injection, powder, lyophilized, for solution; Kit, Solution, Kit - Subcutaneous, Liquid; Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution, Solution - Subcutaneous, Injection, solution, Liquid; Powder, for solution, Injection, powder, for solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, lyophilized, for solution; Kit - Subcutaneous, Injection, Kit; Powder, for solution - Intramuscular; Subcutaneous, Injection - Subcutaneous, Kit - Intramuscular; Subcutaneous, Liquid, Liquid - Subcutaneous, Powder, for solution - Intramuscular; Subcutaneous, Kit; Powder, for solution - Subcutaneous, Parenteral
Warnings
Soma has twelve contraindications and should not be used while suffering from any of the conditions indicated in the following table.Soma ContraindicationsCondition
Risk Level
Notes
Obstructive Sleep Apnea (OSA)
Do Not Combine
Open Heart Surgery
Do Not Combine
Intracranial Tumors
Do Not Combine
Lung Diseases, Obstructive
Do Not Combine
Severe Non-proliferative Diabetic Retinopathy
Do Not Combine
Active Solid Malignancy
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Somatotropin may interact with Toxoplasma Infections
Royer Syndrome
Do Not Combine
Severe Respiratory Disease
Do Not Combine
Acute Respiratory Failure
Do Not Combine
active Proliferative Diabetic Retinopathy (PDR)
Do Not Combine
Closed Epiphyses
Do Not Combine
Common Soma Drug Interactions
Drug Name
Risk Level
Description
Acenocoumarol
Major
The metabolism of Acenocoumarol can be increased when combined with Somatotropin.
Aminophylline
Major
The metabolism of Aminophylline can be increased when combined with Somatotropin.
Anagrelide
Major
The metabolism of Anagrelide can be increased when combined with Somatotropin.
Axitinib
Major
The metabolism of Axitinib can be increased when combined with Somatotropin.
Bendamustine
Major
The metabolism of Bendamustine can be increased when combined with Somatotropin.
Soma Toxicity & Overdose RiskThe lowest toxic dose of somatropin in rats is 242 mg/kg orally, 828 mg/kg when inhaling, and 1100 mg/kg when applied to the skin. Overdose on somatropin can lead to episodes of low and then high blood sugar levels, swelling, and in more extreme cases, the signs and symptoms of gigantism and acromegaly.
Soma Novel Uses: Which Conditions Have a Clinical Trial Featuring Soma?
Currently, 178 active trials are underway to assess the potential of Soma to manage Chronic Kidney Disease, Turners Syndrome and provide Nutritional Support.Condition
Clinical Trials
Trial Phases
Kidney Transplant
31 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 4
Chronic Kidney Disease
113 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 4, Phase 3, Early Phase 1
Turners Syndrome
0 Actively Recruiting
Nutritional Support
0 Actively Recruiting
Height standard deviation score (HSDS) of less than or equal to-2.25
0 Actively Recruiting
Noonan Syndrome
3 Actively Recruiting
Phase 3, Not Applicable
Parkinson Disease
0 Actively Recruiting
Open epiphyses
0 Actively Recruiting
Disease
0 Actively Recruiting
Adult Onset Growth Hormone Deficiency
3 Actively Recruiting
Phase 3, Phase 2
Human Growth Hormone Deficiency
9 Actively Recruiting
Phase 3, Phase 2, Phase 4
Acquired disease
0 Actively Recruiting
Congenital Diseases
0 Actively Recruiting
HIV Wasting Syndrome
0 Actively Recruiting
Antiretroviral Therapy
2 Actively Recruiting
Phase 3, Phase 1
No catch-up growth by age 2 to 4 years
0 Actively Recruiting
Royer Syndrome
11 Actively Recruiting
Phase 4, Phase 2, Not Applicable
Short Stature
1 Actively Recruiting
Phase 2
Pituitary Diseases
6 Actively Recruiting
Not Applicable, Phase 3, Phase 2
SHOX deficiency
0 Actively Recruiting
Soma Reviews: What are patients saying about Soma?
5Patient Review
4/3/2014 This prescription has helped me a lot with my severe back and neck pain. I'm able to sleep better at night, but during the day I still have a lot of pain and stiffness when I try to do things like shower or get dressed.
5Patient Review
9/24/2014 This medication has been a godsend for my back spasms and Fibromyalgia. I was getting no relief from flexeril or zanaflex, but this drug has helped immensely. The only downside is the occasional drowsiness, but that's a small price to pay for being pain-free!
5Patient Review
4/15/2015 I suffered severe back trauma due to a slip and fall about 4 years ago. Even with shots for pain and physical therapy, this medication has helped me immensely. There are days where the pain is so bad I can't even stand up or sit down, but taking a soma alleviates the pain enough for me to function. It doesn't last forever, but it helps so much.
5Patient Review
5/17/2015 I started taking soma for fibromyalgia 20 years ago to help with my sleep. It did help me sleep better, so I took 350 mg at bedtime. However, over time I developed a number of different symptoms that went away when I stopped taking soma:1) A very high white blood cell count2) Heart arrhythmia3) Several attacks a day feeling sick all over like I had the flu that lasted about one minute each time.I feel much better now that I've stopped taking Soma.
5Patient Review
6/28/2015 This medication helps me fall asleep and stay asleep, which is a huge relief. I've been struggling with insomnia for years. When taken in conjunction with a sleeping pill, this drug finally allows me to get some much-needed rest.
5Patient Review
1/31/2022 This drug has been a godsend for my back spasms and tension headaches. I've never had any issues with addiction, but I can understand why some people might abuse them if they don't need them. They are hard on the stomach, so it's best to take them with food.
5Patient Review
4/27/2022 I've been taking this medication for over two decades, but my doctor recently stopped prescribing it. I've tried other muscle relaxers, but none of them work as well. I have a neck injury, and this was the only thing that provided relief.
5Patient Review
5/15/2014 I had a good experience with this drug and am curious about what other drugs it might interact with.
3Patient Review
4/5/2014 Out of all the muscle relaxers I've tried, Soma is by far the most effective for me in terms of managing back spasms and fibromyalgia.
3Patient Review
3/29/2014